Apixaban antithrombotics

Eliquis - BMS-562247 - BMS562247 - BMS 562247


Acute coronary syndrome

All ACS (including AMI):  3 trials  -  APPRAISE-1 (10mg od)  •  APPRAISE 2  •  APPRAISE-1 (2.5 mg bid)

All type of patient:  3 trials  -  APPRAISE 2  •  APPRAISE-1 (2.5 mg bid)  •  APPRAISE-1 (10mg od)

All type of patients:  3 trials  -  APPRAISE-1 (2.5 mg bid)  •  APPRAISE-1 (10mg od)  •  APPRAISE 2

Patients with a recent ACS:  3 trials  -  APPRAISE 2  •  APPRAISE-1 (2.5 mg bid)  •  APPRAISE-1 (10mg od)

Atrial fibrillation

All type of patients :  3 trials  -  ARISTOTLE  •  AVERROES  •  phase 2 apixaban

Patients ineligible for warfarin:  1 trials  -  AVERROES

Primary prevention of thromboembolic events:  3 trials  -  ARISTOTLE  •  AVERROES  •  phase 2 apixaban

DVT prophylaxis

elective major knee surgery :  3 trials  -  ADVANCE-1  •  ADVANCE 2  •  APROPOS 2.5mg

All type of patients :  5 trials  -  ADOPT  •  ADVANCE 3  •  ADVANCE-1  •  ADVANCE 2  •  APROPOS 2.5mg

Elective hip replacement:  1 trials  -  ADVANCE 3

Elective major knee surgery :  2 trials  -  ADVANCE 2  •  APROPOS 2.5mg

Medical patients:  1 trials  -  ADOPT

Orthopaedic surgery:  4 trials  -  ADVANCE 3  •  ADVANCE-1  •  ADVANCE 2  •  APROPOS 2.5mg

Orthopedic surgery :  4 trials  -  ADVANCE-1  •  ADVANCE 2  •  APROPOS 2.5mg  •  ADVANCE 3

Pulmonary embolism

2 trials  -  AMPLIFY  •  AMPLIFY-EXT 2.5mg

Venous thrombosis

secondary prevention of VTE :  1 trials  -  AMPLIFY-EXT 2.5mg

All type of patients:  3 trials  -  AMPLIFY-EXT 2.5mg  •  AMPLIFY  •  Botticelli DVT

All types of patients:  3 trials  -  Botticelli DVT  •  AMPLIFY  •  AMPLIFY-EXT 2.5mg